Suchergebnisse - "Vesole, David H"

PubPharm (210)

1

Outcomes of Modified Mayo Stage IIIa and IIIb Cardiac Light-Chain Amyloidosis : Real-World Experience in Clinical Characteristics and Treatment-67 Patients Multicenter Analysis

enthalten in: Cancers | 2024

von Charliński, G. | Steinhardt, M. | Rasche, L. | +15

2

Outcomes of Patients with Heavily Pretreated Relapsed/Refractory Multiple Myeloma Receiving Salvage Cytotoxic Therapy with Supportive Stem Cell Boost

enthalten in: Current stem cell research & therapy | 2024

von Bangolo, A. | Oza, S. | Slotky, R. | +6

3

Outcome of Second Primary Malignancies Developing in Multiple Myeloma Patients

enthalten in: Cancers | 2023

von Avivi, I. | Vesole, D. | Davila-Valls, J. | +27

4

Impact of bortezomib-based versus lenalidomide maintenance therapy on outcomes of patients with high-risk multiple myeloma

enthalten in: Cancer | 2023

von Bumma, N. | Dhakal, B. | Fraser, R. | +23

5

A Multicenter Phase II, Double-Blind, Placebo-Controlled Trial of Maintenance Ixazomib After Allogeneic Transplantation for High-Risk Multiple Myeloma : Results of the Blood and Marrow Transplant Clinical Trials Network 1302 Trial

enthalten in: Transplantation and cellular therapy | 2023

von Bashir, Q. | Nishihori, T. | Pasquini, M. | +17

6

Impact of second primary malignancy post-autologous transplantation on outcomes of multiple myeloma : a CIBMTR analysis

enthalten in: Blood advances | 2023

von Ragon, B. | Shah, M. | D'Souza, A. | +39

CommentIn: Blood Adv. 2023 Jun 27;7(12):2731-2732. - PMID 37318936

7

Hospital facility characteristics and socioeconomic factors on outcomes and treatment in patients with multiple myeloma : National Cancer Database analysis

enthalten in: Annals of hematology | 2023

von Doucette, K. | Taylor, A. | Chan, B. | +4

8

Interaction between age and gender on survival outcomes in extramedullary multiple myeloma over the past two decades

enthalten in: World journal of clinical oncology | 2023

von Bangolo, A. | Fwelo, P. | Trivedi, C. | +26

9

The Current State of Knowledge About Evolution of Multiple Myeloma to Plasma Cell Leukemia

enthalten in: Clinical lymphoma, myeloma & leukemia | 2023

von Jurczyszyn, A. | Olszewska-Szopa, M. | Vesole, D.

10

Impact of bortezomib‐based versus lenalidomide maintenance therapy on outcomes of patients with high‐risk multiple myeloma

enthalten in: Cancer | 2023

von Bumma, N. | Dhakal, B. | Fraser, R. | +23

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[21]